Literature DB >> 16582601

Cyclin e overexpression reduces infiltrative growth in breast cancer: yet another link between proliferation control and tumor invasion.

Pontus Berglund1, Göran Landberg.   

Abstract

Overexpression of cyclin E is strongly linked to an aggressive phenotype and poor prognosis in breast cancer. Unexpectedly, it has been shown that cyclin E overexpression decreases mobility and invasiveness of breast cancer cells. In fact, in a study of 985 breast cancers, cyclin E correlated with less infiltrative growth. This suggests a novel function for cyclin E in breast cancer tumorigenesis and a mutual control of proliferation and invasive behavior.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16582601     DOI: 10.4161/cc.5.6.2569

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  10 in total

Review 1.  Beyond the histone tale: HP1α deregulation in breast cancer epigenetics.

Authors:  Johan Vad-Nielsen; Anders Lade Nielsen
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

2.  Cadmium promotes breast cancer cell proliferation by potentiating the interaction between ERalpha and c-Jun.

Authors:  Christina L Siewit; Bridget Gengler; Esera Vegas; Rachel Puckett; Maggie C Louie
Journal:  Mol Endocrinol       Date:  2010-03-10

3.  Reduced spermatogonial proliferation and decreased fertility in mice overexpressing cyclin E in spermatogonia.

Authors:  Vasco Liberal; Maria P De Miguel; Martha Henze; Manuel Nistal; Steven I Reed
Journal:  Cell Cycle       Date:  2010-10-04       Impact factor: 4.534

4.  The molecular genetics of breast cancer and targeted therapy.

Authors:  Rachel Suter; James A Marcum
Journal:  Biologics       Date:  2007-09

5.  Prognostic value of cyclin E expression in breast cancer: a meta-analysis.

Authors:  Sheng Gao; Jing-Jing Ma; Cheng Lu
Journal:  Tumour Biol       Date:  2013-06-18

6.  Adenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication.

Authors:  Xinyu Zheng; Xiao-Mei Rao; Jorge G Gomez-Gutierrez; Hongying Hao; Kelly M McMasters; H Sam Zhou
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

7.  Cyclin-dependent kinase 2/cyclin E complex is involved in p120 catenin (p120ctn)-dependent cell growth control: a new role for p120ctn in cancer.

Authors:  Nicolas T Chartier; Christiane I Oddou; Michèle G Lainé; Benjamin Ducarouge; Christiane A Marie; Marc R Block; Muriel R Jacquier-Sarlin
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701

8.  Effects of nickel on cyclin expression, cell cycle progression and cell proliferation in human pulmonary cells.

Authors:  Jin Ding; Guoping He; Wenfeng Gong; Wen Wen; Wen Sun; Beifang Ning; Shanna Huang; Kun Wu; Chuanshu Huang; Mengchao Wu; Weifen Xie; Hongyang Wang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06       Impact factor: 4.254

9.  Heterochromatin protein 1alpha: a hallmark of cell proliferation relevant to clinical oncology.

Authors:  Leanne De Koning; Alexia Savignoni; Charlène Boumendil; Haniya Rehman; Bernard Asselain; Xavier Sastre-Garau; Geneviève Almouzni
Journal:  EMBO Mol Med       Date:  2009-06       Impact factor: 12.137

10.  Regulatory dissection of the CBX5 and hnRNPA1 bi-directional promoter in human breast cancer cells reveals novel transcript variants differentially associated with HP1α down-regulation in metastatic cells.

Authors:  Johan Vad-Nielsen; Kristine Raaby Jakobsen; Tina Fuglsang Daugaard; Rune Thomsen; Anja Brügmann; Boe Sandahl Sørensen; Anders Lade Nielsen
Journal:  BMC Cancer       Date:  2016-01-20       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.